Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IQVIA
CRO
2023 clinical trial launches drop 15% YOY
Yearly clinical trial launches are leveling out, dropping below pre-pandemic highs with a 15% decline in 2023 compared to 2022.
Gabrielle Masson
Feb 22, 2024 8:00am
IQVIA yearly revenues rise 4% amid concerns of slowing demand
Feb 21, 2024 4:25pm
IQVIA teams with CEPI to address future global disease outbreaks
Oct 12, 2023 7:20am
Madrigal COO departs days after new CEO starts—Chutes & Ladders
Sep 29, 2023 9:30am
PD-1 R&D tapers off as new molecules capture interest: IQVIA
May 24, 2023 2:09pm
IQVIA partners with Alibaba Cloud to expand services in China
Feb 2, 2023 8:00am